ALK-Abelló
217,60 DKK
+1,59 %
Under 1K följer bolaget
ALK B
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Översikt
Nyckeltal & Estimat
Ägarlista
Investerarkonsensus
Värdering
Resultaträkning
Kvartalsuppgifter
Kvartalsuppgifter
| Q1/24 | Q2/24 | Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | |
|---|---|---|---|---|---|---|---|---|
| Omsättning | 1 351,0 | 1 374,0 | 1 313,0 | 1 499,0 | 5 537,0 | 1 522,0 | 1 527,0 | 1 530,0 |
| EBITDA | 382,0 | 331,0 | 369,0 | 281,0 | 1 363,0 | 540,0 | 450,0 | 510,0 |
| EBIT | 316,0 | 264,0 | 306,0 | 205,0 | 1 091,0 | 469,0 | 375,0 | 423,0 |
| EBIT-% | 23,4 % | 19,2 % | 23,3 % | 13,7 % | 19,7 % | 30,8 % | 24,6 % | 27,6 % |
| Vinst före skatt | 309,0 | 269,0 | 281,0 | 198,0 | 1 057,0 | 473,0 | 350,0 | 419,0 |
| Nettoresultat | 232,0 | 201,0 | 212,0 | 170,0 | 815,0 | 354,0 | 263,0 | 314,0 |